In the medical technology project of NIVAB of the TROUT company, a worldwide new system for non-invasive determination of blood glucose level will be developed. In opposition to common systems, blood has to be taken only for device calibration. Apart from that using the NIVAB sensor is pain-free.
Another advantage of the system is the continuous data acquisition. Common systems only provide selective data which can comprise large time lags. Glucose values involved in the mentioned time lags, e.g. amplitudes to hyper or hypo glucemia, will not be captured. Actually the NIVAB sensor records a glucose value every minute. This will lead to a consistent curve and to improved possibilities of diagnosis and to more suitable therapies. The non-invasive approach also reduces the risk of infection to a minimum, because there is no need for using a lancet device for blood withdrawal.